Interstitial Lung Disease
Conditions
Interventions
Chinese Medicine Exposure Group:Use of Chinese medicine only (Chinese herbal tonics or proprietary Chinese medicines, etc.)
Western medicine non-exposed group:Use of Western medicine only (hormones, immunosuppressants and antifibrotic drugs, etc.)
Chinese and Western Medicine Exposure Group:Chinese medicine treatment combined with Western medicine
Sponsors
Guangdong Provincial Hospital ofl Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: (1) Unlimited gender age =18 years; (2) Comply with the 2002 American Thoracic Society (ATS) and European Respiratory Society (ERS) Expert Group Consensus the 2018 Chinese Expert Consensus on the Diagnosis and Treatment of Connective Tissue Disease-Related Interstitial Lung Disease the 2019 Chinese Expert Consensus on the Diagnosis and Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis and the 2022 Clinical Practice for Adults with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis Guidelines for the diagnostic criteria of interstitial lung disease including acute exacerbation and stable stage; (3) Patients volunteered to participate in the whole management of the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with combined serious cardiovascular haematological hepatic renal and other organ dysfunctions; (2) Those with mental illnesses who cannot co-operate with the research study; (3) Acute and chronic infectious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FVC%;DLCO SB%;Annual incidence of acute exacerbations; | — |
Secondary
| Measure | Time frame |
|---|---|
| GAD-7;All-cause mortality;PHQ-9;mMRC scale;Chinese Medicine Dampness Assessment Scale;(Cough sputum shortness of breath chest tightness) VAS score;Indicators for prognostic assessment of fibrosis;Tumour indicators;Number of acute exacerbations per year;Chinese medicine factors;SGRQ;CAT Scale;Chinese medicine evidence;Inflammation indicators;Advances in Chest CT Imaging;Duration of the disease;HAQ; | — |
Countries
China
Contacts
Public ContactYuanbin Chen
Guangdong Provincial Hospital ofl Chinese Medicine
Outcome results
None listed